Industry Research Reports

Home > Reports > Medical Devices & Consumables > Global and United States Nuclear Radiopharmaceutical Market Report & Forecast 2024-2030

Global and United States Nuclear Radiopharmaceutical Market Report & Forecast 2024-2030

Industry: Medical Devices & Consumables

Published Date: 2024-09-13

Pages: 136 Pages

Report ld: 3320246

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Nuclear Radiopharmaceutical Market Size(US$)

CAGR 2024-2030

7.3%

Market Size,2030

USD 10,180

Million

Market Snapshot

Market Size in 2024 (Value)

US$ 6,678 million

Market Forecast in 2030(Value)

US$ 10,180 million

CAGR

7.3%

Years Considered

2019-2030

Base Year

2024

Forecast Period

2024-2030

Source: Secondary research, interviews with experts, and QYResearch analysis

Radiopharmaceuticals are radioisotopes bound to biological molecules able to target specific organs, tissues or cells within the human body. These radioactive drugs can be used for the diagnosis and, increasingly, for the therapy of diseases.

Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.

The global Nuclear Radiopharmaceutical revenue was US$ 6124 million in 2023 and is forecast to a readjusted size of US$ 10180 million by 2030 with a CAGR of 7.3% during the review period (2024-2030).

In United States the Nuclear Radiopharmaceutical revenue is expected to grow from US$ million in 2023 to US$ million by 2030, at a CAGR of % during the forecast period (2024-2030).

This report focuses on global and United States Nuclear Radiopharmaceutical market, also covers the segmentation data of other regions in regional level and county level.

The radiopharmaceutical market is driven primarily by the growing prevalence of cancer and cardiovascular diseases, which require precise diagnostic tools for early detection and treatment. The increasing adoption of nuclear medicine imaging techniques, such as PET and SPECT scans, has further fueled demand for radiopharmaceuticals. Additionally, technological advancements in radiopharmaceuticals, along with the development of new radioisotopes for more targeted therapies, are expanding the applications of these drugs, making them critical in personalized medicine.

Despite the promising growth, the radiopharmaceutical market faces significant challenges, including the high cost of production and the short half-life of many radioisotopes, which complicates distribution and storage. Regulatory hurdles are another barrier, as radiopharmaceuticals require stringent approval processes due to their radioactive nature. Moreover, limited availability of specialized infrastructure and the shortage of trained professionals in nuclear medicine also hinder widespread adoption, especially in developing regions.

There is widespread awareness of the use of radiation and radioisotopes in medicine, particularly for diagnosis (identification) and therapy (treatment) of various medical conditions. In developed countries (a quarter of the world population) about one person in 50 uses diagnostic nuclear medicine each year, and the frequency of therapy with radioisotopes is about one-tenth of this.

Nuclear medicine uses radiation to provide information about the functioning of a person's specific organs, or to treat disease. In most cases, the information is used by physicians to make a quick diagnosis of the patient's illness. The thyroid, bones, heart, liver, and many other organs can be easily imaged, and disorders in their function revealed. In some cases radiation can be used to treat diseased organs, or tumours.

Over 10,000 hospitals worldwide use radioisotopes in medicine, and about 90% of the procedures are for diagnosis. The most common radioisotope used in diagnosis is technetium-99 (Tc-99m) accounting for about 80% of all nuclear medicine procedures and 85% of diagnostic scans in nuclear medicine worldwide.Over 50 million nuclear medicine procedures are performed each year, and demand for radioisotopes is increasing.

Nuclear Radiopharmaceutical market is segmented in regional and country level, by players, by Type, and by Application. Companies, stakeholders, and other participants in the global Nuclear Radiopharmaceutical market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2019-2030.

For United States market, this report focuses on the Nuclear Radiopharmaceutical market size by players, by Type, and by Application, for the period 2019-2030. The key players include the global and local players which play important roles in United States.

MARKET SEGMENTATION

By Company

Cardinal Health
GE Healthcare
Jubilant Pharma
Novartis
Curium Pharma
SIEMENS
Lantheus
Bracco Imaging
Bayer
Eli Lilly
Aurobindo Pharma
Mundipharma
China Isotope & Radiation
Dongcheng

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Diagnostic Radiopharmaceuticals
Therapeutic Radiopharmaceuticals

Segment by Application

Oncology
Thyroid
Cardiology
Others

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces Nuclear Radiopharmaceutical definition, global sales (volume and revenue), United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Provides the analysis of various market segments by Type, covering the volume, price, revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by Application, covering the revenue, price, volume, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Detailed analysis of Nuclear Radiopharmaceutical companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Revenue and volume of Nuclear Radiopharmaceutical in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 6: Americas by Type, by Application and by country, sales, and revenue for each segment.

Chapter 7: EMEA by Type, by Application and by region, sales, and revenue for each segment.

Chapter 8: China by Type, and by Application, sales, and revenue for each segment.

Chapter 9: APAC (excluding China) by Type, by Application and by region, sales, and revenue for each segment.

Chapter 10: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Nuclear Radiopharmaceutical sales, revenue, gross margin, and recent development, etc.

Chapter 11: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.

Chapter 12: research findings and conclusion

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Study Coverage

1.1 Nuclear Radiopharmaceutical Product Introduction

1.2 Global Nuclear Radiopharmaceutical Outlook 2019 VS 2023 VS 2030

1.2.1 Global Nuclear Radiopharmaceutical Sales in US$ Million for the Year 2019-2030

1.2.2 Global Nuclear Radiopharmaceutical Sales in Volume for the Year 2019-2030

1.3 United States Nuclear Radiopharmaceutical Outlook 2019 VS 2023 VS 2030

1.3.1 United States Nuclear Radiopharmaceutical Sales in US$ Million for the Year 2019-2030

1.3.2 United States Nuclear Radiopharmaceutical Sales in Volume for the Year 2019-2030

1.4 Nuclear Radiopharmaceutical Market Size, United States VS Global, 2019 VS 2023 VS 2030

1.4.1 The Market Share of United States Nuclear Radiopharmaceutical in Global, 2019 VS 2023 VS 2030

1.4.2 The Growth Rate of Nuclear Radiopharmaceutical Market Size, United States VS Global, 2019 VS 2023 VS 2030

1.5 Nuclear Radiopharmaceutical Market Dynamics

1.5.1 Nuclear Radiopharmaceutical Industry Trends

1.5.2 Nuclear Radiopharmaceutical Market Drivers

1.5.3 Nuclear Radiopharmaceutical Market Challenges

1.5.4 Nuclear Radiopharmaceutical Market Restraints

1.6 Assumptions and Limitations

1.7 Study Objectives

1.8 Years Considered

2 Nuclear Radiopharmaceutical by Type

2.1 Nuclear Radiopharmaceutical Market by Type

2.1.1 Diagnostic Radiopharmaceuticals

2.1.2 Therapeutic Radiopharmaceuticals

2.2 Global Nuclear Radiopharmaceutical Market Size by Type

2.2.1 Global Nuclear Radiopharmaceutical Sales in Value, by Type (2019, 2023 & 2030)

2.2.2 Global Nuclear Radiopharmaceutical Sales in Volume, by Type (2019, 2023 & 2030)

2.2.3 Global Nuclear Radiopharmaceutical Average Selling Price (ASP) by Type (2019, 2023 & 2030)

2.3 United States Nuclear Radiopharmaceutical Market Size by Type

2.3.1 United States Nuclear Radiopharmaceutical Sales in Value, by Type (2019, 2023 & 2030)

2.3.2 United States Nuclear Radiopharmaceutical Sales in Volume, by Type (2019, 2023 & 2030)

2.3.3 United States Nuclear Radiopharmaceutical Average Selling Price (ASP) by Type (2019, 2023 & 2030)

3 Nuclear Radiopharmaceutical by Application

3.1 Nuclear Radiopharmaceutical Market by Application

3.1.1 Oncology

3.1.2 Thyroid

3.1.3 Cardiology

3.1.4 Others

3.2 Global Nuclear Radiopharmaceutical Market Size by Application

3.2.1 Global Nuclear Radiopharmaceutical Sales in Value, by Application (2019, 2023 & 2030)

3.2.2 Global Nuclear Radiopharmaceutical Sales in Volume, by Application (2019, 2023 & 2030)

3.2.3 Global Nuclear Radiopharmaceutical Average Selling Price (ASP) by Application (2019, 2023 & 2030)

3.3 United States Nuclear Radiopharmaceutical Market Size by Application

3.3.1 United States Nuclear Radiopharmaceutical Sales in Value, by Application (2019, 2023 & 2030)

3.3.2 United States Nuclear Radiopharmaceutical Sales in Volume, by Application (2019, 2023 & 2030)

3.3.3 United States Nuclear Radiopharmaceutical Average Selling Price (ASP) by Application (2019, 2023 & 2030)

4 Global Nuclear Radiopharmaceutical Competitor Landscape by Company

4.1 Global Nuclear Radiopharmaceutical Market Size by Company

4.1.1 Global Key Manufacturers of Nuclear Radiopharmaceutical, Ranked by Revenue (2023)

4.1.2 Global Nuclear Radiopharmaceutical Revenue by Manufacturer (2019-2024)

4.1.3 Global Nuclear Radiopharmaceutical Sales by Manufacturer (2019-2024)

4.1.4 Global Nuclear Radiopharmaceutical Price by Manufacturer (2019-2024)

4.2 Global Nuclear Radiopharmaceutical Concentration Ratio (CR)

4.2.1 Nuclear Radiopharmaceutical Market Concentration Ratio (CR) (2019-2024)

4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Nuclear Radiopharmaceutical in 2023

4.2.3 Global Nuclear Radiopharmaceutical Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

4.3 Global Key Manufacturers of Nuclear Radiopharmaceutical, Manufacturing Base Distribution and Headquarters

4.4 Global Key Manufacturers of Nuclear Radiopharmaceutical, Product Offered and Application

4.5 Global Key Manufacturers of Nuclear Radiopharmaceutical, Date of Enter into This Industry

4.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4.7 United States Nuclear Radiopharmaceutical Market Size by Company

4.7.1 Key Players of Nuclear Radiopharmaceutical in United States, Ranked by Revenue (2023)

4.7.2 United States Nuclear Radiopharmaceutical Revenue by Players (2019-2024)

4.7.3 United States Nuclear Radiopharmaceutical Sales by Players (2019-2024)

5 Global Nuclear Radiopharmaceutical Market Size by Region

5.1 Global Nuclear Radiopharmaceutical Market Size by Region: 2019 VS 2023 VS 2030

5.2 Global Nuclear Radiopharmaceutical Market Size in Volume by Region (2019-2030)

5.2.1 Global Nuclear Radiopharmaceutical Sales in Volume by Region: 2019-2024

5.2.2 Global Nuclear Radiopharmaceutical Sales in Volume Forecast by Region (2025-2030)

5.3 Global Nuclear Radiopharmaceutical Market Size in Value by Region (2019-2030)

5.3.1 Global Nuclear Radiopharmaceutical Sales in Value by Region: 2019-2024

5.3.2 Global Nuclear Radiopharmaceutical Sales in Value by Region: 2025-2030

6 Americas

6.1 Americas Nuclear Radiopharmaceutical Market Size YoY Growth 2019-2030

6.2 Americas Nuclear Radiopharmaceutical Sales in Volume, by Type (2019, 2023 & 2030)

6.3 Americas Nuclear Radiopharmaceutical Sales in Volume, by Application (2019, 2023 & 2030)

6.4 Americas Nuclear Radiopharmaceutical Market Facts & Figures by Country (2019, 2023 & 2030)

6.4.1 Americas Nuclear Radiopharmaceutical Sales in Value by Country (2019, 2023 & 2030)

6.4.2 Americas Nuclear Radiopharmaceutical Sales in Volume by Country (2019, 2023 & 2030)

6.4.3 United States

6.4.4 Canada

6.4.5 Mexico

6.4.6 Brazil

7 EMEA

7.1 EMEA Nuclear Radiopharmaceutical Market Size YoY Growth 2019-2030

7.2 EMEA Nuclear Radiopharmaceutical Sales in Volume, by Type (2019, 2023 & 2030)

7.3 EMEA Nuclear Radiopharmaceutical Sales in Volume, by Application (2019, 2023 & 2030)

7.4 EMEA Nuclear Radiopharmaceutical Market Facts & Figures by Country (2019, 2023 & 2030)

7.4.1 EMEA Nuclear Radiopharmaceutical Sales in Value by Country (2019, 2023 & 2030)

7.4.2 EMEA Nuclear Radiopharmaceutical Sales in Volume by Country (2019, 2023 & 2030)

7.4.3 Europe

7.4.4 Middle East

7.4.5 Africa

8 China

8.1 China Nuclear Radiopharmaceutical Market Size YoY Growth 2019-2030

8.2 China Nuclear Radiopharmaceutical Sales in Volume, by Type (2019, 2023 & 2030)

8.3 China Nuclear Radiopharmaceutical Sales in Volume, by Application (2019, 2023 & 2030)

9 APAC

9.1 APAC Nuclear Radiopharmaceutical Market Size YoY Growth 2019-2030

9.2 APAC Nuclear Radiopharmaceutical Sales in Volume, by Type (2019, 2023 & 2030)

9.3 APAC Nuclear Radiopharmaceutical Sales in Volume, by Application (2019, 2023 & 2030)

9.4 APAC Nuclear Radiopharmaceutical Market Facts & Figures by Country (2019, 2023 & 2030)

9.4.1 APAC Nuclear Radiopharmaceutical Sales in Value by Country (2019, 2023 & 2030)

9.4.2 APAC Nuclear Radiopharmaceutical Sales in Volume by Country (2019, 2023 & 2030)

9.4.3 Japan

9.4.4 South Korea

9.4.5 China Taiwan

9.4.6 Southeast Asia

9.4.7 India

10 Company Profiles

10.1 Cardinal Health

10.1.1 Cardinal Health Company Information

10.1.2 Cardinal Health Description and Business Overview

10.1.3 Cardinal Health Nuclear Radiopharmaceutical Sales, Revenue and Gross Margin (2019-2024)

10.1.4 Cardinal Health Nuclear Radiopharmaceutical Products Offered

10.1.5 Cardinal Health Recent Development

10.2 GE Healthcare

10.2.1 GE Healthcare Company Information

10.2.2 GE Healthcare Description and Business Overview

10.2.3 GE Healthcare Nuclear Radiopharmaceutical Sales, Revenue and Gross Margin (2019-2024)

10.2.4 GE Healthcare Nuclear Radiopharmaceutical Products Offered

10.2.5 GE Healthcare Recent Development

10.3 Jubilant Pharma

10.3.1 Jubilant Pharma Company Information

10.3.2 Jubilant Pharma Description and Business Overview

10.3.3 Jubilant Pharma Nuclear Radiopharmaceutical Sales, Revenue and Gross Margin (2019-2024)

10.3.4 Jubilant Pharma Nuclear Radiopharmaceutical Products Offered

10.3.5 Jubilant Pharma Recent Development

10.4 Novartis

10.4.1 Novartis Company Information

10.4.2 Novartis Description and Business Overview

10.4.3 Novartis Nuclear Radiopharmaceutical Sales, Revenue and Gross Margin (2019-2024)

10.4.4 Novartis Nuclear Radiopharmaceutical Products Offered

10.4.5 Novartis Recent Development

10.5 Curium Pharma

10.5.1 Curium Pharma Company Information

10.5.2 Curium Pharma Description and Business Overview

10.5.3 Curium Pharma Nuclear Radiopharmaceutical Sales, Revenue and Gross Margin (2019-2024)

10.5.4 Curium Pharma Nuclear Radiopharmaceutical Products Offered

10.5.5 Curium Pharma Recent Development

10.6 SIEMENS

10.6.1 SIEMENS Company Information

10.6.2 SIEMENS Description and Business Overview

10.6.3 SIEMENS Nuclear Radiopharmaceutical Sales, Revenue and Gross Margin (2019-2024)

10.6.4 SIEMENS Nuclear Radiopharmaceutical Products Offered

10.6.5 SIEMENS Recent Development

10.7 Lantheus

10.7.1 Lantheus Company Information

10.7.2 Lantheus Description and Business Overview

10.7.3 Lantheus Nuclear Radiopharmaceutical Sales, Revenue and Gross Margin (2019-2024)

10.7.4 Lantheus Nuclear Radiopharmaceutical Products Offered

10.7.5 Lantheus Recent Development

10.8 Bracco Imaging

10.8.1 Bracco Imaging Company Information

10.8.2 Bracco Imaging Description and Business Overview

10.8.3 Bracco Imaging Nuclear Radiopharmaceutical Sales, Revenue and Gross Margin (2019-2024)

10.8.4 Bracco Imaging Nuclear Radiopharmaceutical Products Offered

10.8.5 Bracco Imaging Recent Development

10.9 Bayer

10.9.1 Bayer Company Information

10.9.2 Bayer Description and Business Overview

10.9.3 Bayer Nuclear Radiopharmaceutical Sales, Revenue and Gross Margin (2019-2024)

10.9.4 Bayer Nuclear Radiopharmaceutical Products Offered

10.9.5 Bayer Recent Development

10.10 Eli Lilly

10.10.1 Eli Lilly Company Information

10.10.2 Eli Lilly Description and Business Overview

10.10.3 Eli Lilly Nuclear Radiopharmaceutical Sales, Revenue and Gross Margin (2019-2024)

10.10.4 Eli Lilly Nuclear Radiopharmaceutical Products Offered

10.10.5 Eli Lilly Recent Development

10.11 Aurobindo Pharma

10.11.1 Aurobindo Pharma Company Information

10.11.2 Aurobindo Pharma Description and Business Overview

10.11.3 Aurobindo Pharma Nuclear Radiopharmaceutical Sales, Revenue and Gross Margin (2019-2024)

10.11.4 Aurobindo Pharma Nuclear Radiopharmaceutical Products Offered

10.11.5 Aurobindo Pharma Recent Development

10.12 Mundipharma

10.12.1 Mundipharma Company Information

10.12.2 Mundipharma Description and Business Overview

10.12.3 Mundipharma Nuclear Radiopharmaceutical Sales, Revenue and Gross Margin (2019-2024)

10.12.4 Mundipharma Nuclear Radiopharmaceutical Products Offered

10.12.5 Mundipharma Recent Development

10.13 China Isotope & Radiation

10.13.1 China Isotope & Radiation Company Information

10.13.2 China Isotope & Radiation Description and Business Overview

10.13.3 China Isotope & Radiation Nuclear Radiopharmaceutical Sales, Revenue and Gross Margin (2019-2024)

10.13.4 China Isotope & Radiation Nuclear Radiopharmaceutical Products Offered

10.13.5 China Isotope & Radiation Recent Development

10.14 Dongcheng

10.14.1 Dongcheng Company Information

10.14.2 Dongcheng Description and Business Overview

10.14.3 Dongcheng Nuclear Radiopharmaceutical Sales, Revenue and Gross Margin (2019-2024)

10.14.4 Dongcheng Nuclear Radiopharmaceutical Products Offered

10.14.5 Dongcheng Recent Development

11 Industry Chain and Sales Channels Analysis

11.1 Nuclear Radiopharmaceutical Industry Chain Analysis

11.2 Nuclear Radiopharmaceutical Key Raw Materials

11.2.1 Key Raw Materials

11.2.2 Raw Materials Key Suppliers

11.3 Nuclear Radiopharmaceutical Production Mode & Process

11.4 Nuclear Radiopharmaceutical Sales and Marketing

11.4.1 Nuclear Radiopharmaceutical Sales Channels

11.4.2 Nuclear Radiopharmaceutical Distributors

11.5 Nuclear Radiopharmaceutical Customers

12 Research Findings and Conclusion

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Nuclear Radiopharmaceutical CAGR in Value, United States VS Global, 2019 VS 2023 VS 2030

Table 2. Nuclear Radiopharmaceutical Market Trends

Table 3. Nuclear Radiopharmaceutical Market Drivers

Table 4. Nuclear Radiopharmaceutical Market Challenges

Table 5. Nuclear Radiopharmaceutical Market Restraints

Table 6. Global Nuclear Radiopharmaceutical Sales Growth Rate (CAGR) by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 7. United States Nuclear Radiopharmaceutical Sales Growth Rate (CAGR) by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 8. Global Nuclear Radiopharmaceutical Sales Growth Rate (CAGR) by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 9. United States Nuclear Radiopharmaceutical Sales Growth Rate (CAGR) by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 10. Global Key Manufacturers of Nuclear Radiopharmaceutical, Ranked by Revenue (2023) & (US$ Million)

Table 11. Global Nuclear Radiopharmaceutical Revenue by Manufacturer, (US$ Million) & (2019-2024)

Table 12. Global Nuclear Radiopharmaceutical Revenue Share by Manufacturer, 2019-2024

Table 13. Global Nuclear Radiopharmaceutical Sales by Manufacturer, (K Units), 2019-2024

Table 14. Global Nuclear Radiopharmaceutical Sales Share by Manufacturer, 2019-2024

Table 15. Global Nuclear Radiopharmaceutical Price by Manufacturer (2019-2024) & (US$/Unit)

Table 16. Global Nuclear Radiopharmaceutical Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 17. Global Nuclear Radiopharmaceutical by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Radiopharmaceutical as of 2023)

Table 18. Global Key Manufacturers of Nuclear Radiopharmaceutical, Manufacturing Base Distribution and Headquarters

Table 19. Global Key Manufacturers of Nuclear Radiopharmaceutical, Product Offered and Application

Table 20. Global Key Manufacturers of Nuclear Radiopharmaceutical, Date of Enter into This Industry

Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 22. Key Players of Nuclear Radiopharmaceutical in United States, Ranked by Revenue (2023) & (US$ million)

Table 23. United States Nuclear Radiopharmaceutical Revenue by Players, (US$ Million) & (2019-2024)

Table 24. United States Nuclear Radiopharmaceutical Revenue Share by Players, (2019-2024)

Table 25. United States Nuclear Radiopharmaceutical Sales by Players, (K Units) & (2019-2024)

Table 26. United States Nuclear Radiopharmaceutical Sales Share by Players, (2019-2024)

Table 27. Global Nuclear Radiopharmaceutical Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 28. Global Nuclear Radiopharmaceutical Sales in Volume by Region (2019-2024) & (K Units)

Table 29. Global Nuclear Radiopharmaceutical Sales in Volume Forecast by Region (2025-2030) & (K Units)

Table 30. Global Nuclear Radiopharmaceutical Sales in Value by Region (2019-2024) & (US$ Million)

Table 31. Global Nuclear Radiopharmaceutical Sales in Value Forecast by Region (2025-2030) & (US$ Million)

Table 32. Americas Nuclear Radiopharmaceutical Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 33. Americas Nuclear Radiopharmaceutical Sales in Value by Country (2019-2024) & (US$ Million)

Table 34. Americas Nuclear Radiopharmaceutical Sales in Value by Country (2025-2030) & (US$ Million)

Table 35. Americas Nuclear Radiopharmaceutical Sales in Volume by Country (2019-2024) & (K Units)

Table 36. Americas Nuclear Radiopharmaceutical Sales in Volume by Country (2025-2030) & (K Units)

Table 37. EMEA Nuclear Radiopharmaceutical Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. EMEA Nuclear Radiopharmaceutical Sales in Value by Country (2019-2024) & (US$ Million)

Table 39. EMEA Nuclear Radiopharmaceutical Sales in Value by Country (2025-2030) & (US$ Million)

Table 40. EMEA Nuclear Radiopharmaceutical Sales in Volume by Country (2019-2024) & (K Units)

Table 41. EMEA Nuclear Radiopharmaceutical Sales in Volume by Country (2025-2030) & (K Units)

Table 42. APAC Nuclear Radiopharmaceutical Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. APAC Nuclear Radiopharmaceutical Sales in Value by Country (2019-2024) & (US$ Million)

Table 44. APAC Nuclear Radiopharmaceutical Sales in Value by Country (2025-2030) & (US$ Million)

Table 45. APAC Nuclear Radiopharmaceutical Sales in Volume by Country (2019-2024) & (K Units)

Table 46. APAC Nuclear Radiopharmaceutical Sales in Volume by Country (2025-2030) & (K Units)

Table 47. Cardinal Health Company Information

Table 48. Cardinal Health Description and Business Overview

Table 49. Cardinal Health Nuclear Radiopharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 50. Cardinal Health Nuclear Radiopharmaceutical Product

Table 51. Cardinal Health Recent Development

Table 52. GE Healthcare Company Information

Table 53. GE Healthcare Description and Business Overview

Table 54. GE Healthcare Nuclear Radiopharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 55. GE Healthcare Nuclear Radiopharmaceutical Product

Table 56. GE Healthcare Recent Development

Table 57. Jubilant Pharma Company Information

Table 58. Jubilant Pharma Description and Business Overview

Table 59. Jubilant Pharma Nuclear Radiopharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 60. Jubilant Pharma Nuclear Radiopharmaceutical Product

Table 61. Jubilant Pharma Recent Development

Table 62. Novartis Company Information

Table 63. Novartis Description and Business Overview

Table 64. Novartis Nuclear Radiopharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 65. Novartis Nuclear Radiopharmaceutical Product

Table 66. Novartis Recent Development

Table 67. Curium Pharma Company Information

Table 68. Curium Pharma Description and Business Overview

Table 69. Curium Pharma Nuclear Radiopharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 70. Curium Pharma Nuclear Radiopharmaceutical Product

Table 71. Curium Pharma Recent Development

Table 72. SIEMENS Company Information

Table 73. SIEMENS Description and Business Overview

Table 74. SIEMENS Nuclear Radiopharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 75. SIEMENS Nuclear Radiopharmaceutical Product

Table 76. SIEMENS Recent Development

Table 77. Lantheus Company Information

Table 78. Lantheus Description and Business Overview

Table 79. Lantheus Nuclear Radiopharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 80. Lantheus Nuclear Radiopharmaceutical Product

Table 81. Lantheus Recent Development

Table 82. Bracco Imaging Company Information

Table 83. Bracco Imaging Description and Business Overview

Table 84. Bracco Imaging Nuclear Radiopharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 85. Bracco Imaging Nuclear Radiopharmaceutical Product

Table 86. Bracco Imaging Recent Development

Table 87. Bayer Company Information

Table 88. Bayer Description and Business Overview

Table 89. Bayer Nuclear Radiopharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 90. Bayer Nuclear Radiopharmaceutical Product

Table 91. Bayer Recent Development

Table 92. Eli Lilly Company Information

Table 93. Eli Lilly Description and Business Overview

Table 94. Eli Lilly Nuclear Radiopharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 95. Eli Lilly Nuclear Radiopharmaceutical Product

Table 96. Eli Lilly Recent Development

Table 97. Aurobindo Pharma Company Information

Table 98. Aurobindo Pharma Description and Business Overview

Table 99. Aurobindo Pharma Nuclear Radiopharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 100. Aurobindo Pharma Nuclear Radiopharmaceutical Product

Table 101. Aurobindo Pharma Recent Development

Table 102. Mundipharma Company Information

Table 103. Mundipharma Description and Business Overview

Table 104. Mundipharma Nuclear Radiopharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 105. Mundipharma Nuclear Radiopharmaceutical Product

Table 106. Mundipharma Recent Development

Table 107. China Isotope & Radiation Company Information

Table 108. China Isotope & Radiation Description and Business Overview

Table 109. China Isotope & Radiation Nuclear Radiopharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 110. China Isotope & Radiation Nuclear Radiopharmaceutical Product

Table 111. China Isotope & Radiation Recent Development

Table 112. Dongcheng Company Information

Table 113. Dongcheng Description and Business Overview

Table 114. Dongcheng Nuclear Radiopharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 115. Dongcheng Nuclear Radiopharmaceutical Product

Table 116. Dongcheng Recent Development

Table 117. Key Raw Materials Lists

Table 118. Raw Materials Key Suppliers Lists

Table 119. Nuclear Radiopharmaceutical Distributors List

Table 120. Nuclear Radiopharmaceutical Customers List

Table 121. Research Programs/Design for This Report

Table 122. Key Data Information from Secondary Sources

Table 123. Key Data Information from Primary Sources

List of Figures

Figure 1. Nuclear Radiopharmaceutical Product Picture

Figure 2. Global Nuclear Radiopharmaceutical Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 3. Global Nuclear Radiopharmaceutical Market Size 2019-2030 (US$ Million)

Figure 4. Global Nuclear Radiopharmaceutical Sales 2019-2030 (K Units)

Figure 5. United States Nuclear Radiopharmaceutical Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 6. United States Nuclear Radiopharmaceutical Market Size 2019-2030 (US$ Million)

Figure 7. United States Nuclear Radiopharmaceutical Sales 2019-2030 (K Units)

Figure 8. United States Nuclear Radiopharmaceutical Market Share in Global, in Value (US$ Million) 2019-2030

Figure 9. United States Nuclear Radiopharmaceutical Market Share in Global, in Volume (K Units) 2019-2030

Figure 10. Nuclear Radiopharmaceutical Report Years Considered

Figure 11. Product Picture of Diagnostic Radiopharmaceuticals

Figure 12. Product Picture of Therapeutic Radiopharmaceuticals

Figure 13. Global Nuclear Radiopharmaceutical Market Share by Type in 2023 & 2030

Figure 14. Global Nuclear Radiopharmaceutical Sales in Value by Type (2019-2030) & (US$ Million)

Figure 15. Global Nuclear Radiopharmaceutical Sales Market Share in Value by Type (2019-2030)

Figure 16. Global Nuclear Radiopharmaceutical Sales by Type (2019-2030) & (K Units)

Figure 17. Global Nuclear Radiopharmaceutical Sales Market Share in Volume by Type (2019-2030)

Figure 18. Global Nuclear Radiopharmaceutical Price by Type (2019-2030) & (US$/Unit)

Figure 19. United States Nuclear Radiopharmaceutical Market Share by Type in 2023 & 2030

Figure 20. United States Nuclear Radiopharmaceutical Sales in Value by Type (2019-2030) & (US$ Million)

Figure 21. United States Nuclear Radiopharmaceutical Sales Market Share in Value by Type (2019-2030)

Figure 22. United States Nuclear Radiopharmaceutical Sales by Type (2019-2030) & (K Units)

Figure 23. United States Nuclear Radiopharmaceutical Sales Market Share in Volume by Type (2019-2030)

Figure 24. United States Nuclear Radiopharmaceutical Price by Type (2019-2030) & (US$/Unit)

Figure 25. Product Picture of Oncology

Figure 26. Product Picture of Thyroid

Figure 27. Product Picture of Cardiology

Figure 28. Product Picture of Others

Figure 29. Global Nuclear Radiopharmaceutical Market Share by Application in 2023 & 2030

Figure 30. Global Nuclear Radiopharmaceutical Sales in Value by Application (2019-2030) & (US$ Million)

Figure 31. Global Nuclear Radiopharmaceutical Sales Market Share in Value by Application (2019-2030)

Figure 32. Global Nuclear Radiopharmaceutical Sales by Application (2019-2030) & (K Units)

Figure 33. Global Nuclear Radiopharmaceutical Sales Market Share in Volume by Application (2019-2030)

Figure 34. Global Nuclear Radiopharmaceutical Price by Application (2019-2030) & (US$/Unit)

Figure 35. United States Nuclear Radiopharmaceutical Market Share by Application in 2023 & 2030

Figure 36. United States Nuclear Radiopharmaceutical Sales in Value by Application (2019-2030) & (US$ Million)

Figure 37. United States Nuclear Radiopharmaceutical Sales Market Share in Value by Application (2019-2030)

Figure 38. United States Nuclear Radiopharmaceutical Sales by Application (2019-2030) & (K Units)

Figure 39. United States Nuclear Radiopharmaceutical Sales Market Share in Volume by Application (2019-2030)

Figure 40. United States Nuclear Radiopharmaceutical Price by Application (2019-2030) & (US$/Unit)

Figure 41. The Top 5 and 10 Largest Manufacturers of Nuclear Radiopharmaceutical in the World: Market Share by Nuclear Radiopharmaceutical Revenue in 2023

Figure 42. Global Nuclear Radiopharmaceutical Market Size Market Share by Region: 2019 VS 2023 VS 2030

Figure 43. Global Nuclear Radiopharmaceutical Sales in Volume Market Share by Region (2019-2030)

Figure 44. Global Nuclear Radiopharmaceutical Sales in Value Market Share by Region (2019-2030)

Figure 45. Americas Nuclear Radiopharmaceutical Sales in Volume Growth Rate 2019-2030 (K Units)

Figure 46. Americas Nuclear Radiopharmaceutical Sales in Value Growth Rate 2019-2030 (US$ Million)

Figure 47. Americas Nuclear Radiopharmaceutical Sales by Type (2019-2030) & (K Units)

Figure 48. Americas Nuclear Radiopharmaceutical Sales Market Share in Volume by Type (2019-2030)

Figure 49. Americas Nuclear Radiopharmaceutical Sales by Application (2019-2030) & (K Units)

Figure 50. Americas Nuclear Radiopharmaceutical Sales Market Share in Volume by Application (2019-2030)

Figure 51. United States Nuclear Radiopharmaceutical Sales in Value Growth Rate (2019-2030) & (US$ Million)

Figure 52. Canada Nuclear Radiopharmaceutical Sales in Value Growth Rate (2019-2030) & (US$ Million)

Figure 53. Mexico Nuclear Radiopharmaceutical Sales in Value Growth Rate (2019-2030) & (US$ Million)

Figure 54. Brazil Nuclear Radiopharmaceutical Sales in Value Growth Rate (2019-2030) & (US$ Million)

Figure 55. EMEA Nuclear Radiopharmaceutical Sales in Volume Growth Rate 2019-2030 (K Units)

Figure 56. EMEA Nuclear Radiopharmaceutical Sales in Value Growth Rate 2019-2030 (US$ Million)

Figure 57. EMEA Nuclear Radiopharmaceutical Sales by Type (2019-2030) & (K Units)

Figure 58. EMEA Nuclear Radiopharmaceutical Sales Market Share in Volume by Type (2019-2030)

Figure 59. EMEA Nuclear Radiopharmaceutical Sales by Application (2019-2030) & (K Units)

Figure 60. EMEA Nuclear Radiopharmaceutical Sales Market Share in Volume by Application (2019-2030)

Figure 61. Europe Nuclear Radiopharmaceutical Sales in Value Growth Rate (2019-2030) & (US$ Million)

Figure 62. Middle East Nuclear Radiopharmaceutical Sales in Value Growth Rate (2019-2030) & (US$ Million)

Figure 63. Africa Nuclear Radiopharmaceutical Sales in Value Growth Rate (2019-2030) & (US$ Million)

Figure 64. China Nuclear Radiopharmaceutical Sales in Volume Growth Rate 2019-2030 (K Units)

Figure 65. China Nuclear Radiopharmaceutical Sales in Value Growth Rate 2019-2030 (US$ Million)

Figure 66. China Nuclear Radiopharmaceutical Sales by Type (2019-2030) & (K Units)

Figure 67. China Nuclear Radiopharmaceutical Sales Market Share in Volume by Type (2019-2030)

Figure 68. China Nuclear Radiopharmaceutical Sales by Application (2019-2030) & (K Units)

Figure 69. China Nuclear Radiopharmaceutical Sales Market Share in Volume by Application (2019-2030)

Figure 70. APAC Nuclear Radiopharmaceutical Sales in Volume Growth Rate 2019-2030 (K Units)

Figure 71. APAC Nuclear Radiopharmaceutical Sales in Value Growth Rate 2019-2030 (US$ Million)

Figure 72. APAC Nuclear Radiopharmaceutical Sales by Type (2019-2030) & (K Units)

Figure 73. APAC Nuclear Radiopharmaceutical Sales Market Share in Volume by Type (2019-2030)

Figure 74. APAC Nuclear Radiopharmaceutical Sales by Application (2019-2030) & (K Units)

Figure 75. APAC Nuclear Radiopharmaceutical Sales Market Share in Volume by Application (2019-2030)

Figure 76. Japan Nuclear Radiopharmaceutical Sales in Value Growth Rate (2019-2030) & (US$ Million)

Figure 77. South Korea Nuclear Radiopharmaceutical Sales in Value Growth Rate (2019-2030) & (US$ Million)

Figure 78. China Taiwan Nuclear Radiopharmaceutical Sales in Value Growth Rate (2019-2030) & (US$ Million)

Figure 79. Southeast Asia Nuclear Radiopharmaceutical Sales in Value Growth Rate (2019-2030) & (US$ Million)

Figure 80. India Nuclear Radiopharmaceutical Sales in Value Growth Rate (2019-2030) & (US$ Million)

Figure 81. Nuclear Radiopharmaceutical Value Chain

Figure 82. Nuclear Radiopharmaceutical Production Process

Figure 83. Channels of Distribution (Direct Vs Distribution)

Figure 84. Bottom-up and Top-down Approaches for This Report

Figure 85. Data Triangulation

Figure 86. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What was the global market size of Nuclear Radiopharmaceutical in 2030? zhanKai

The global market size of Nuclear Radiopharmaceutical in 2030 was 10180 Million USD.

Which region is expected to have the highest market share? shouQi

What was the global market size of Nuclear Radiopharmaceutical in 2024? shouQi

Which companies rank high in the global Nuclear Radiopharmaceutical market? shouQi

What is the annual compound growth rate of the global Nuclear Radiopharmaceutical market size from 2024 to 2030? shouQi

Related Reports

Nuclear Radiopharmaceutical- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Nuclear Radiopharmaceutical was estimated to be worth US$ 7116 million in 2025 and is projected to reach US$ 11560 million, growing at a CAGR of 7.3% from 2026 to 2032.
Published Date: 2026-02-11
Pages: 114
USD 3950.00
(Single User License)
Global Nuclear Radiopharmaceutical Market Research Report 2026
The global Nuclear Radiopharmaceutical market was valued at US$ 7116 million in 2025 and is anticipated to reach US$ 11560 million by 2032, at a CAGR of 7.3% from 2026 to 2032.
Published Date: 2026-02-11
Pages: 126
USD 2900.00
(Single User License)
Global Nuclear Radiopharmaceutical Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Nuclear Radiopharmaceutical market is projected to grow from US$ 6678 million in 2024 to US$ 10850 million by 2031, at a CAGR of 7.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-03
Pages: 167
USD 4900.00
(Single User License)
Global Nuclear Radiopharmaceutical Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Nuclear Radiopharmaceutical market size was US$ 6678 million in 2024 and is forecast to a readjusted size of US$ 10850 million by 2031 with a CAGR of 7.3% during the forecast period 2025-2031.
Published Date: 2025-02-14
Pages: 96
USD 4250.00
(Single User License)
Nuclear Radiopharmaceutical- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Nuclear Radiopharmaceutical was estimated to be worth US$ 6678 million in 2024 and is forecast to a readjusted size of US$ 10850 million by 2031 with a CAGR of 7.3% during the forecast period 2025-2031.
Published Date: 2025-02-14
Pages: 113
USD 3950.00
(Single User License)
Global Nuclear Radiopharmaceutical Market Research Report 2025
The global market for Nuclear Radiopharmaceutical was valued at US$ 6678 million in the year 2024 and is projected to reach a revised size of US$ 10850 million by 2031, growing at a CAGR of 7.3% during the forecast period.
Published Date: 2025-02-14
Pages: 94
USD 2900.00
(Single User License)
Nuclear Radiopharmaceutical- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Radiopharmaceuticals are radioisotopes bound to biological molecules able to target specific organs, tissues or cells within the human body. These radioactive drugs can be used for the diagnosis and, increasingly, for the therapy of diseases.
Published Date: 2024-09-13
Pages: 127
USD 3950.00
(Single User License)
Global Nuclear Radiopharmaceutical Market Insights, Forecast to 2030
Radiopharmaceuticals are radioisotopes bound to biological molecules able to target specific organs, tissues or cells within the human body. These radioactive drugs can be used for the diagnosis and, increasingly, for the therapy of diseases.
Published Date: 2024-09-13
Pages: 146
USD 4900.00
(Single User License)
Global Nuclear Radiopharmaceutical Market Research Report 2024
Radiopharmaceuticals are radioisotopes bound to biological molecules able to target specific organs, tissues or cells within the human body. These radioactive drugs can be used for the diagnosis and, increasingly, for the therapy of diseases.
Published Date: 2024-09-13
Pages: 88
USD 2900.00
(Single User License)
Nuclear Radiopharmaceutical - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nuclear Radiopharmaceuticals consist primarily of a radioactive isotope that is incorporated into a drug to assess the disease state in the body. The drug is used to deliver the radioactive isotope to an organ, tissue or specific cell in the body.
Published Date: 2024-01-04
Pages: 114
USD 3950.00
(Single User License)

Nuclear Radiopharmaceutical- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Nuclear Radiopharmaceutical was estimated to be worth US$ 7116 million in 2025 and is projected to reach US$ 11560 million, growing at a CAGR of 7.3% from 2026 to 2032.
Published: 2026-02-11
Pages: 114
USD 3950.00 (Single User License)
Global Nuclear Radiopharmaceutical Market Research Report 2026
The global Nuclear Radiopharmaceutical market was valued at US$ 7116 million in 2025 and is anticipated to reach US$ 11560 million by 2032, at a CAGR of 7.3% from 2026 to 2032.
Published: 2026-02-11
Pages: 126
USD 2900.00 (Single User License)
Global Nuclear Radiopharmaceutical Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Nuclear Radiopharmaceutical market is projected to grow from US$ 6678 million in 2024 to US$ 10850 million by 2031, at a CAGR of 7.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-03
Pages: 167
USD 4900.00 (Single User License)
Global Nuclear Radiopharmaceutical Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Nuclear Radiopharmaceutical market size was US$ 6678 million in 2024 and is forecast to a readjusted size of US$ 10850 million by 2031 with a CAGR of 7.3% during the forecast period 2025-2031.
Published: 2025-02-14
Pages: 96
USD 4250.00 (Single User License)
Nuclear Radiopharmaceutical- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Nuclear Radiopharmaceutical was estimated to be worth US$ 6678 million in 2024 and is forecast to a readjusted size of US$ 10850 million by 2031 with a CAGR of 7.3% during the forecast period 2025-2031.
Published: 2025-02-14
Pages: 113
USD 3950.00 (Single User License)
Global Nuclear Radiopharmaceutical Market Research Report 2025
The global market for Nuclear Radiopharmaceutical was valued at US$ 6678 million in the year 2024 and is projected to reach a revised size of US$ 10850 million by 2031, growing at a CAGR of 7.3% during the forecast period.
Published: 2025-02-14
Pages: 94
USD 2900.00 (Single User License)
Nuclear Radiopharmaceutical- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Radiopharmaceuticals are radioisotopes bound to biological molecules able to target specific organs, tissues or cells within the human body. These radioactive drugs can be used for the diagnosis and, increasingly, for the therapy of diseases.
Published: 2024-09-13
Pages: 127
USD 3950.00 (Single User License)
Global Nuclear Radiopharmaceutical Market Insights, Forecast to 2030
Radiopharmaceuticals are radioisotopes bound to biological molecules able to target specific organs, tissues or cells within the human body. These radioactive drugs can be used for the diagnosis and, increasingly, for the therapy of diseases.
Published: 2024-09-13
Pages: 146
USD 4900.00 (Single User License)
Global Nuclear Radiopharmaceutical Market Research Report 2024
Radiopharmaceuticals are radioisotopes bound to biological molecules able to target specific organs, tissues or cells within the human body. These radioactive drugs can be used for the diagnosis and, increasingly, for the therapy of diseases.
Published: 2024-09-13
Pages: 88
USD 2900.00 (Single User License)
Nuclear Radiopharmaceutical - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nuclear Radiopharmaceuticals consist primarily of a radioactive isotope that is incorporated into a drug to assess the disease state in the body. The drug is used to deliver the radioactive isotope to an organ, tissue or specific cell in the body.
Published: 2024-01-04
Pages: 114
USD 3950.00 (Single User License)